This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Aortic Stents Grafts Market

Aortic Stents Grafts Market by Product Type (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), End User (Hospitals, Ambulatory Surgical Centers/ Outpatient Surgical Centers), and Region for 2022 and 2028

Aortic Stents Grafts Market by Product Type (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), End User (Hospitals, Ambulatory Surgical Centers/ Outpatient Surgical Centers), and Region for 2022 and 2028

Aortic Stents Grafts Market - Analysis, Outlook, Growth, Trends, Forecasts

Aortic Stents Grafts Market Outlook – 2022-2028

[215 Pages Report] The global Aortic Stents Grafts Market is forecast to total US$ 2.15 Bn in 2022. With increasing preference for minimally invasive procedures, the overall market is projected to grow at 4.5% CAGR, reaching a valuation of around 2.8 Bn by 2028.

Attribute

Details

Aortic Stents Grafts Estimated Market Size in 2022

US$ 2.15 Bn

Aortic Stents Grafts Market value-based CAGR (2022-2028)

4.5%

Aortic Stents Grafts Market Projected Size in 2028

US$ 2.8 Bn

Abdominal aortic stent graft segment is set to retain its dominance in the global aortic stents grafts market, accounting for 91.0% share in 2022. Increasing prevalence of abdominal aortic aneurysm (AAA) is spurring the sales of abdominal aortic stent grafts.

2017-2021 Aortic Stents Grafts Market Outlook Compared to 2022-2028 Forecast

The aortic stents grafts market is set to register a steady CAGR of 4.5% between 2022 and 2028 in comparison to 4.7% CAGR registered from 2017 to 2021.

According to Future Market Insights (FMI), the increasing prevalence of aneurysm, rising geriatric population, unhealthy lifestyle, and growing popularity of endovascular repair are some of the factors driving the aortic stents grafts market.

Endovascular repair has emerged as a standard treatment for people suffering from abdominal aortic aneurysm and an alternative for patients who do not qualify for open surgery. The treatment involves an artificial stent graft, delivered through an atrial blood vessel in the groin, fixed over the widening.

Rising cases of aortic aneurysm (AA) across the world is a major force behind the expanding aortic stents grafts market. According to a report published in National Library of Medicine (LHM), an estimated 167,249 deaths due to aortic aneurysm (AA) were recorded globally in 2017.

Increasing number of screening procedures for early detection of aneurysm coupled with bourgeoning geriatric male population is playing a significant role in expanding the aortic stents grafts market. As aneurysm disorders such as AAA are asymptomatic, early diagnosis can prevent the rupture and thus enable the expert to initiate the proper treatment procedure.

Rising number of clinical trials and continuous advancement in stent graft designs for improving the endovascular aneurysm repair will continue to boost the global aortic stents grafts market.

For instance, in July 2021, a multidisciplinary team led by Drs. Gustavo Oderich, Anthony Estrera, Naveed Saqib and others from Department of Cardiothoracic & Vascular Surgery, successfully performed the first total percutaneous endovascular three-vessel arch branch stent graft in the Americas and the United States.

Growing awareness among people regarding the benefits of minimally invasive endovascular aneurysm repair procedures will continue to accelerate the growth of aortic stents grafts market during the forecast period.

Spurred by aforementioned factors, the aortic stent grafts market is expected to surpass US$ 2.8 Bn through 2028.

Will Demand for Minimally Invasive Procedures Continue Driving Aortic Stent Grafts Market?

Traditionally, the only way to get rid of an aneurysm was to repair it with a surgery (open surgery) or by taking medications. However, with the rapid advancement in medical technology, innovative minimally invasive procedures began gaining traction.

Rising concerns regarding the life-threatening consequences of aneurysm is prompting the patients to opt for quick and minimally invasive procedures such as endovascular aneurysm repair (EVAR). These approaches are especially ideal for those patients who cannot qualify for open surgeries.

During EVAR, a catheter is inserted into the blood vessels through a small incision in the groin for delivering an artificial stent graft to the aneurysm location. The graft is then expanded inside the aorta and fastened in proper place.

Today, endovascular repair procedures such as abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR) and thoracic endovascular aneurysm repair (TEVAR) have become standard treatment for aneurysm.

As these procedures are safe, effective, less costly and reduce the operative time, majority of the people opt for them. Success of these procedures largely depend on the use of image guidance techniques including X-rays.

FMI, predicts aortic stents grafts market to expand 1.3X amid growing preference for minimally invasive procedures for the treatment of aneurysm.

How are Favorable Reimbursement Policies Help Supporting Aortic Stent Grafts Market Players?

One of the key concerns for aortic stents grafts market is the high cost associated with endovascular aneurysm repair procedures. A large portion of middle- and lower-class people are not in a state to bear the treatment cost.

However, the introduction of favorable reimbursement policies has changed the whole scenario. Countries such as the U.S. and the U.K. have already implemented reimbursement policies for aortic aneurysm procedures.

Emergence of reimbursement policies in developing regions with higher patient pool will create lucrative growth prospects for key players during the forecast period.

Country-wise Insights

What is Driving the U.S. Aortic Stent Grafts Market?

As per FMI, aortic stents grafts market in the U.S. will expand at a CAGR of 4.9% between 2022 and 2028. Growth in the country is attributed to the growing preference for minimally invasive procedures, presence of favorable reimbursement policies, higher prevalence of smoking habits,  and increasing incidence of aortic aneurysm.

According to the Centers for Disease Control and Prevention (CDC), an estimated 9,904 people in the U.S. died due to aortic aneurysm or aortic dissections in 2019. Moreover, around 75% of all abdominal aortic aneurysms had a history of smoking.

Amid rising mortality rate due to abdominal aortic aneurysm, various government and private organizations are pushing for proper screening. For instance, the U.S. Preventive Services Task Force has recommended men aged between 65 to 75 years older who have ever smoked to get an ultrasound screening for abdominal aortic aneurysms, even if they have no symptoms.

In order to reduce this burden, thousands of minimally invasive endovascular repair procedures are being performed across the U.S. This is in turn spurring the sales of aortic stent Grafts.

What are the Growth Projections for the U.K. Aortic Stent Grafts Market?

The U.K market is projected to register a steady CAGR of 4.8% over the forecast period of 2022 and 2028. Expanding healthcare infrastructure, advances in minimally invasive procedures, soaring male geriatric population and rising patient pool suffering from aortic aneurysms and other heart related diseases.

As per the British Society of Interventional Radiology (BSIR), around 4% (approx. 80000) of men aged between 65 and 74 in England have an abdominal aortic aneurysm (AAA). Furthermore around 6000 people succumb to AAA annually in England and Wales.

To tackle this aneurysm burden, large number of endovascular repair procedures are being performed annually in the U.K. This is creating huge demand for aortic stent graft products.

How will the Growth Unfold in China Aortic Stents Grafts Market?

As per FMI, the aortic stents grafts market in China is set to register the fastest growth, expanding at a CAGR of 5.5% between 2022 and 2028. Market in the country is mainly driven by rapidly rising population, increasing prevalence of aortic aneurysm and growing preference for minimally invasive procedures.

With expanding healthcare infrastructure and rapid production of innovative medical devices at cheaper costs, China is emerging as an ideal destination for medical tourists with aneurysm.

Endovascular aneurysm repair (EVAR) procedures in China are performed at very cheap costs. As a result, sales of aortic stent grafts are rising at a significant rate.

Moreover, leading Chinese medical device companies are aiming to penetrate the attractive markets for increasing their sales. This will accelerate the growth of aortic stents grafts market in during the forecast period.

FMI, predicts a market share of 11.8% for Asia Pacific Excluding Japan (APEJ) in 2022, with China leading at the forefront.

Category-wise Insights

Which Product Type Dominates the Aortic Stents Grafts Market?

According to the report, the abdominal aortic stent graft segment is expected to dominate the aortic stents grafts market, accounting for a whooping share of 91.0% by 2022. Rising sales of aortic stent grafts is attributed to the higher patient pool with abdominal aortic aneurysm and hypertension, unhealthy lifestyle and excessive smoking

Abdominal aortic aneurysm (AAA) is the most common type of aneurysm prevalent in men aged 65 and older. It occurs in the part of the aorta that runs through the abdomen. Delay or negligence in proper treatment can lead to serious consequences including death. As a result, large number of endovascular repair procedures are being performed annually.

Rising preference for minimally invasive procedures over open surgeries for the treatment of AAA is spurring the sales of abdominal aortic stent grafts and the trend is likely to continue in the future.

Who is the Leading End User of Aortic Stent Grafts?

In terms of end users, hospitals segment will continue to dominate the aortic stents grafts market, accounting for the largest revenue share over the forecast period.

Rising number of hospitals worldwide and increasing government investments to provide better healthcare facilities are some of the factors driving the demand for aortic stent graft systems. Moreover, due to lack of reimbursement policies and low deposable income in developing regions, people generally opt for the treatment in hospitals.

Competitive Landscape

Leading players operating in the aortic stents grafts market are investing vigorously in research and development activities. Besides this, they are leveraging various growth strategies such as partnerships, acquisitions, collaborations and advanced product launches & approvals to dominate the market.

  • In December 2021, TERUMO Aortic announced PMDA approval of RelayPro thoracic stent graft system for the treatment of patients suffering from thoracic aortic aneurysm (TAA) across Japan. RelayPro is a low profile, next generation thoracic stent-graft device designed to treat thoracic aneurysm patients with smaller access.
  • In May 2021, Endologix LLC, a leader in the treatment of vascular disease, announced the launch of ALTO Abdominal Stent Graft in Canada and Argentina. With this launch, the company expands its endovascular aneurysm repair (EVAR) product portfolio.
  • In March 2020, CryoLife, inc., a leading cardiac and vascular surgery company focused on aortic disease received the CE mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch diseases including both aortic aneurysms and aortic dissections. The company’s new hybrid system offers advanced treatment with cost effective features.
  • Similarly, in September 2020, CryoLife acquired Ascyrus Medical to expand its product portfolio. Ascyrus Medical is the developer of the World’s first aortic arch remodeling device “Ascyrus Medical Dissection Stent (AMDS)”, which is used for the treatment of acute Type A aortic dissection.

In November 2018, Cordis, a Cardinal Health Company received the U.S Food and Drug Administration (FDA) approval for its INCRAFT AAA stent graft system. The INCRAFT system is an ideal endovascular aneurysm repair system designed for the treatment of AAA.

Scope of the Report

Attribute

Details

Forecast Period

2017-2022

Historical Data Available for

2022-2028

Market Analysis

Units for Volume and US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa

Key Countries Covered

US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa

Key Segments Covered

Product Type, End-User and Region

Key Companies Profiled

  • Cook Medical, Inc.
  • W.L. Gore & Associates
  • MicroPort Scientific Corporation Inc.
  • Medtronic Plc.
  • Lombard Medical, Inc.
  • Endologix, INC.
  • Terumo Corporation Inc.
  • Cardinal Health Inc.
  • Becton, Dickinson and Company
  • Cryolife Inc.

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

Aortic Stents Grafts Market By Category

Product Type:

  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatient Surgical Centers

Region:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Western Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Benelux
    • Nordic
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • APEJ
    • China
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of APAC
  • Japan
  • MEA
    • GCC Countries
    • Turkey
    • South Africa
    • North Africa
    • Rest of MEA

Key Questions Answered in the Report

What is the aortic stents grafts market valuation?

The aortic stents grafts market is estimated to be worth around US$ 2.15 Bn in 2022.
As per FMI, the aortic stents grafts market is forecast to register a CAGR of 4.5% between 2022 and 2028.
The aortic stents grafts market grew at a CAGR of 4.7% between 2017 and 2021.
Growing preference for minimally invasive procedures, introduction of favorable reimburse policies and increasing number of FDA product approvals are some of the key trends shaping the market growth.
The North American aortic stents grafts market demand is set to account for 43.8% share in 2022.
The aortic stents grafts market in Europe is projected to account for 25.1% by 2022.
Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc. Are some of the leading players operating in the aortic stents grafts market.
Japan is anticipated to register a CAGR of 4.2% between 2022 and 2028.

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Patient Controlled Analgesia Pumps Market

Published : 2017-12-05

Healthcare

Breast Pump Market 122017

Published : 2020-06-24

Healthcare

Single Photon Emission Computed Tomography Market

Published : 2017-12-21

Healthcare

Phototherapy Lamps Market

Published : 2017-12-22